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Arbi Pecani†, Cristiano Alessandri*†, Francesca Romana Spinelli, Roberta Priori, Valeria Riccieri, Manuela Di Franco,
Fulvia Ceccarelli, Tania Colasanti, Monica Pendolino, Riccardo Mancini, Simona Truglia, Cristiana Barbati,
Marta Vomero, Danilo Sabatinelli, Francesca Morello, Guido Valesini and Fabrizio ContiResults
Anti-CarP antibodies were detected in 117 patients with RA (37.9%), ACPA in 190 patients (61.4%) and RF in 202
patients (65.3%). Two (2.04%) of the NHS were positive for anti-CarP, one NHS (1.02%) was positive for ACPA and
three NHS were positive for RF (3.06%). Among disease controls, anti-CarP antibodies were detected in 33 patients
(16.5%), ACPA in 29 patients (14.5%) and RF in 64 patients (32%). In particular, 16.8% of patients with systemic lupus
erythematosus and 31.1% of patients with Sjögren syndrome were positive for anti-CarP. The sensitivity of anti-CarP,
ACPA and RF was 46.8, 61.8 and 64.4%, respectively and specificity was 91.95, 89.93 and 76.51%, respectively.Erratum
Unfortunately, after publication of this article [1], it was
noticed that the percentage of patients listed as RA positive
was incorrect in two locations. In the ‘Results’ section of
the abstract and in row 1, column 2 of Table 2, the percent-
age was listed as 34.4%. The actual percentage should be
37.9%. The corrected ‘Results’ section of the abstract can be
seen above and the corrected Table 2 can be seen below.
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Table 2 Prevalence of anti-CarP, ACPA and RF in RA patients, disease controls and healthy subjects
Disease
(No of patients)
Anti-CarP positive n, (%) ACPA positive n, (%) RF positive n, (%)
RA (309) 117 (37.9) 190 (61.4) 202 (65.3)
NHS (98) 2 (2.04) 1 (1.02) 3 (3.06)
SLE (83) 14 (16.8) 15 (18.07) 19 (22.8)
SS (45) 14 (31.1) 11 (24.4) 23 (51.1)
SSc (51) 3 (5.8) 1 (1.9) 18 (35.2)
OP (21) 2 (9.5) 2 (9.5) 4 (19.04)
Anti-CarP anti-carbamylated proteins antibodies, ACPA anti-citrullinated peptides antibodies, RF rheumatoid factor, RA Rheumatoid Arthritis, NHS Normal Healthy
Subjects, SLE Systemic Lupus Erythematosus, SS Sjögren Syndrome, SSc Systemic Sclerosis, OP osteoporosis
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